SCHOTT Pharma
Flavia Painelli has extensive work experience in supply chain management and finance. Flavia is currently serving as the Head of Supply Chain Management at SCHOTT Pharma since 2022. Previously, they worked at SCHOTT from 2011 to 2022, where they held multiple roles including Head of Supply Chain Management and Vice GM Supply Chain & IT Manager in China. Flavia also worked at Newsan as a Planning Manager and at Michelin in various positions including Coordinador Local Supply Chain and Responsable de Facturación. Flavia has also worked as a Finance Management Professor at Universidad de Buenos Aires. Overall, Flavia has a strong background in supply chain management, logistics, and financial administration.
Flavia Painelli completed their education with a Magister en Gestión de Operaciones / Master in Operations Management from Universidad Austral, Buenos Aires in 2017-2018. Flavia also holds an Especialista en Administración Financiera from the University of Buenos Aires from 2009-2011. In addition, they completed a Posgrado en Docencia Universitaria from the University of Buenos Aires in 2009-2010. Flavia Painelli earned a Lic. en Administración from the University of Buenos Aires between 1999 and 2002. Flavia also obtained a College Preparatory Diploma from CMR High School in 1993-1994.
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social